Your browser doesn't support javascript.
loading
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers.
Hagström, Hannes; Ndegwa, Nelson; Jalmeus, Molly; Ekstedt, Mattias; Posserud, Iris; Rorsman, Fredrik; Nyhlin, Nils; Klintman, Daniel; Werner, Mårten; Marschall, Hanns-Ulrich; Askling, Johan; Stål, Per.
Afiliação
  • Hagström H; Division of Hepatology, Department of Upper GI diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Ndegwa N; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Jalmeus M; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Ekstedt M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Posserud I; Division of Surgery, Department of Clinical Science Intervention and Technology, Karolinska Institutet, and Oesophageal and Gastric Cancer Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Rorsman F; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Nyhlin N; Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Klintman D; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Werner M; Department of Gastroenterology and Hepatology, Uppsala University Hospital, Uppsala, Sweden.
  • Marschall HU; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Askling J; Department of Gastroenterology and Hepatology, Skåne University Hospital,, Malmö, Sweden.
  • Stål P; Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden.
Liver Int ; 41(3): 545-553, 2021 03.
Article em En | MEDLINE | ID: mdl-33450138

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Proteína da Hemocromatose / Hemocromatose / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Proteína da Hemocromatose / Hemocromatose / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos